Skip to main content
Local News

AltPep Developing Tests and Treatments for Alzheimer’s and Parkinson’s Disease Raises $52.9M

By June 30, 2023No Comments

University of Washington spinout AltPep, which is developing tests and treatments for Alzheimer’s and Parkinson’s disease, completed a $52.9 million Series B funding round.

The funding will help propel the company’s experimental treatments into clinical trials and support its regulatory application for a blood test to detect Alzheimer’s disease at its earliest stages, according to a statement Thursday announcing the funding.

AltPep targets a form of Amyloid-beta, a molecule that builds up in the brains of people with Alzheimer’s disease years before symptoms appear. These “toxic oligomers” are thought to trigger a host of other pathologies.